Organogenesis Holdings INC. (ORGO) — 10-Q Filings

10-Q Filings (6)

• ORGO's Q3 Net Income Soars 75% on Strong Product Revenue — Nov 6, 2025 Risk: medium
  Organogenesis Holdings Inc. (ORGO) reported a significant increase in net income for the three months ended September 30, 2025, reaching $21.567 million, up fro
• Organogenesis Q2 Revenue Plunges 15%, Swings to $10.5M Loss — Aug 7, 2025 Risk: high
  Organogenesis Holdings Inc. reported a significant decline in revenue and net income for the second quarter ended June 30, 2025. Total net revenue decreased by
• Organogenesis Holdings Inc. Files Q1 2025 10-Q — May 8, 2025 Risk: medium
  Organogenesis Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business operations. Key
• Organogenesis Holdings Inc. Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  Organogenesis Holdings Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business
• Organogenesis Holdings Inc. Files 10-Q for Q2 2024 — Aug 8, 2024 Risk: low
  Organogenesis Holdings Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly Avista Healthcare Public Acquisition Corp., is incorporate
• Organogenesis Holdings Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Organogenesis Holdings Inc. (ORGO) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Organogenesis Holdings Inc. filed a 10-Q report for the period e

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX